Opportunity Information: Apply for CDC RFA PS11 1117
Apply for CDC RFA PS11 1117
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS Phase II" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.523 The Affordable Care Act Human Immunodeficiency Virus (HIV) Prevention and Public Health Fund Activities.
- This funding opportunity was created on Mar 25, 2011 and posted on Mar 25, 2011.
- Applicants must submit their applications by May 25, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $64,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $600,000.00 in funding.
- The number of recipients for this funding is limited to 12 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Applicants eligible to apply for this cooperative agreement are limited to twelve (12) entities in specific Metropolitan Statistical Areas (MSAs) or specified Metropolitan Divisions (MDs) that have the highest estimated AIDS prevalence at the end of 2007. These twelve eligible areas received funding for Phase I of the project under announcement CDC RFA PS10 10181. The entities eligible to apply for funds under this FOA are as follows 1. New York City Department of Health and Mental Hygiene 2. Los Angeles County Public Health Department 3. District of Columbia Department of Health 4. Chicago Department of Public Health 5. Georgia Department of Human Resources 6. Florida State Department of Health 7. City of Philadelphia Public Health Department 8. Houston Department of Health and Human Services 9. San Francisco Department of Public Health 10. Maryland State Department of Health 11. Texas State Department of Health Services 12. Puerto Rico Department of Health
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS Phase II is a CDC cooperative agreement (Funding Opportunity Number CDC RFA PS11-1117) designed to push HIV prevention work in the jurisdictions carrying the heaviest AIDS burden while making sure HIV services are not operating in a silo. The central idea is integration: the program emphasizes coordinated diagnostic, prevention, and related public health activities across HIV, hepatitis C (HCV), hepatitis B (HBV), sexually transmitted diseases (STDs), and tuberculosis (TB). CDC frames this as a practical response to the reality that these infections overlap in the same communities, often spread through similar routes and risk factors, and frequently show up together in the same patients. In other words, improving HIV outcomes and preventing new infections requires also taking TB, viral hepatitis, and STDs seriously as part of the same public health picture.
The public health rationale is grounded in co-infection and shared risk. STDs can increase a persons risk of acquiring HIV, so preventing and treating STDs is also an HIV prevention strategy. TB control is described as essential for protecting the health of people living with HIV, since HIV and TB together can be especially dangerous and TB can speed up HIV disease progression. Viral hepatitis (HBV and HCV) also overlaps with HIV through shared transmission risks and can complicate clinical outcomes. CDC also highlights a disproportionate impact issue: groups most affected by HIV are frequently also those facing higher rates of TB, hepatitis, and STDs, so integrated approaches are positioned as a way to reduce compounded harms and address inequities more directly.
This opportunity was a discretionary grant using a cooperative agreement mechanism, meaning CDC would typically have substantial programmatic involvement compared to a standard grant. It fell under the health funding activity category and was tied to CFDA 93.523, listed as The Affordable Care Act Human Immunodeficiency Virus (HIV) Prevention and Public Health Fund Activities. The program anticipated 12 awards nationwide, reflecting a targeted strategy rather than an open competition across all jurisdictions.
Funding for the announcement was sizable overall, with an estimated total funding amount of $64,000,000. Individual awards were expected to fall between $400,000 (award floor) and $600,000 (award ceiling). There was no cost-sharing or matching requirement, which typically lowers barriers for public agencies implementing prevention and surveillance improvements. The funding opportunity was posted March 25, 2011, with an original and current closing date of May 25, 2011, and it was archived June 24, 2011.
Eligibility was tightly limited. Only twelve entities located in specific Metropolitan Statistical Areas (MSAs) or Metropolitan Divisions (MDs) with the highest estimated AIDS prevalence at the end of 2007 could apply, and these were the same jurisdictions that received Phase I funding under CDC RFA PS10-10181. The eligible applicants were: New York City Department of Health and Mental Hygiene; Los Angeles County Public Health Department; District of Columbia Department of Health; Chicago Department of Public Health; Georgia Department of Human Resources; Florida State Department of Health; City of Philadelphia Public Health Department; Houston Department of Health and Human Services; San Francisco Department of Public Health; Maryland State Department of Health; Texas State Department of Health Services; and the Puerto Rico Department of Health. In effect, this Phase II announcement functioned as a continuation and expansion step for an established cohort of high-burden jurisdictions, aiming to deepen comprehensive planning and implementation rather than start brand-new programs in new locations.
Operationally, while the short description does not list every required activity, it makes clear that CDC expected jurisdictions to strengthen how prevention and diagnostic services are planned and delivered across disease areas that intersect with HIV. The emphasis on integration implies better coordination between HIV programs and STD clinics, hepatitis testing and linkage, and TB screening and treatment connections, along with prevention planning that accounts for overlapping behavioral, clinical, and environmental drivers. The program description also signals that CDC wanted public health systems to respond to the interconnected nature of these epidemics, reducing missed opportunities where a person tested or treated for one condition is not evaluated or supported for the others.
For applicants needing the full announcement at the time, CDC directed people to the Full Announcement and provided a point of contact through the CDC Procurement and Grants Office, Technical Information Management Section (TIMS), at 770-488-2700 for help accessing the materials electronically.
Frequently Asked Questions (FAQs)
1) What is this funding opportunity?
Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS Phase II is a CDC cooperative agreement (Funding Opportunity Number CDC RFA PS11-1117). It is designed to advance HIV prevention work in jurisdictions with the highest AIDS burden while strengthening coordination so HIV services are not delivered in isolation from related public health programs.
2) Who is the funding agency?
The funding agency is the Centers for Disease Control and Prevention (CDC).
3) What does "Phase II" mean in this context?
Phase II indicates a continuation/next step for a defined group of jurisdictions that previously received Phase I funding under CDC RFA PS10-10181. The Phase II announcement focused on deepening comprehensive planning and implementation rather than starting new programs in new locations.
4) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA PS11-1117.
5) What type of award mechanism is this?
This opportunity uses a cooperative agreement mechanism. Compared with a standard grant, a cooperative agreement typically involves substantial programmatic involvement by CDC.
6) What is the main goal or central idea of the program?
The central idea is integration. CDC emphasized coordinated diagnostic, prevention, and related public health activities across HIV, hepatitis C (HCV), hepatitis B (HBV), sexually transmitted diseases (STDs), and tuberculosis (TB), reflecting the reality that these conditions overlap in the same communities and can co-occur in the same patients.
7) Why does CDC emphasize integrating HIV work with STD, TB, and viral hepatitis activities?
The rationale described in the announcement is that these infections share risk factors and transmission routes and frequently affect the same populations. CDC also noted that STDs can increase a person's risk of acquiring HIV, TB control is essential for protecting the health of people living with HIV (and TB can speed HIV disease progression), and HBV/HCV overlap with HIV and can complicate clinical outcomes.
8) How does this opportunity address disproportionate impact or inequities?
CDC highlighted that groups most affected by HIV are often also those experiencing higher rates of TB, hepatitis, and STDs. Integrated approaches were positioned as a way to reduce compounded harms and address inequities more directly by responding to overlapping epidemics together.
9) What is the CFDA number and program listing referenced?
The opportunity is tied to CFDA 93.523, listed as The Affordable Care Act Human Immunodeficiency Virus (HIV) Prevention and Public Health Fund Activities.
10) How many awards did CDC anticipate making?
The program anticipated 12 awards nationwide, reflecting a targeted strategy focused on a specific group of high-burden jurisdictions.
11) What is the estimated total funding amount for this announcement?
The estimated total funding amount was $64,000,000.
12) What was the expected funding range for individual awards?
Individual awards were expected to range from $400,000 (award floor) to $600,000 (award ceiling).
13) Was cost sharing or matching required?
No. The announcement specified there was no cost-sharing or matching requirement.
14) When was the opportunity posted, and what were the closing dates?
It was posted on March 25, 2011. The original and current closing date listed was May 25, 2011. The opportunity was archived on June 24, 2011.
15) Is this opportunity still open?
No. Based on the listed closing date (May 25, 2011) and archive date (June 24, 2011), the opportunity is not open for applications.
16) Who was eligible to apply?
Eligibility was limited to twelve entities located in specific Metropolitan Statistical Areas (MSAs) or Metropolitan Divisions (MDs) with the highest estimated AIDS prevalence at the end of 2007, and they had to be the same jurisdictions that received Phase I funding under CDC RFA PS10-10181.
17) Which jurisdictions/entities were listed as eligible applicants?
The eligible applicants were: New York City Department of Health and Mental Hygiene; Los Angeles County Public Health Department; District of Columbia Department of Health; Chicago Department of Public Health; Georgia Department of Human Resources; Florida State Department of Health; City of Philadelphia Public Health Department; Houston Department of Health and Human Services; San Francisco Department of Public Health; Maryland State Department of Health; Texas State Department of Health Services; and the Puerto Rico Department of Health.
18) Could other states, counties, cities, nonprofits, universities, or healthcare systems apply?
No. The eligibility language provided indicates that only the twelve specified entities/jurisdictions could apply, and they were required to be Phase I recipients. No other applicant types were included in the provided eligibility list.
19) What kinds of activities did CDC expect jurisdictions to strengthen?
While the short description does not list every required activity, it clearly indicates CDC expected stronger planning and delivery of prevention and diagnostic services across intersecting disease areas (HIV, STDs, HBV/HCV, and TB). The integration emphasis implies improved coordination between HIV programs and STD clinics, hepatitis testing and linkage, and TB screening and treatment connections, along with prevention planning that accounts for overlapping drivers of risk.
20) What does "not operating in a silo" mean for this program?
It means HIV services were expected to be coordinated with related public health services rather than run as separate, disconnected programs. The program framing suggests reducing missed opportunities where someone tested or treated for one condition is not evaluated or supported for the others.
21) What geographic focus did CDC use for targeting awards?
The announcement focused on specific MSAs or MDs with the highest estimated AIDS prevalence at the end of 2007, and only the listed jurisdictions were eligible.
22) What funding category was this opportunity associated with?
It fell under the health funding activity category.
23) Where could applicants get the full announcement at the time?
CDC directed people to the Full Announcement and provided a point of contact for help accessing the materials electronically.
24) Who was the point of contact for technical help accessing materials?
The point of contact was the CDC Procurement and Grants Office, Technical Information Management Section (TIMS), reachable at 770-488-2700.
25) Does the provided description list specific required deliverables or a detailed work plan?
No. The provided information describes the goals and integration emphasis but does not enumerate all required activities or deliverables.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: BLM OR WA Native Plant Materials Development, Vale District, Oregon
Previous opportunity: Hispanic Serving Institutions STEM
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS11 1117
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS11 1117) also looked into and applied for these:
| Funding Opportunity |
|---|
| Integrated Economic, Dynamic Disease, Risk and Decision Analytic Modeling of Global and Domestic Policy Issues for Polio Apply for CDC RFA IP11 1102 Funding Number: CDC RFA IP11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Translation of Pluripotent Stem Cell Therapies for Blood Diseases (R01) Apply for PA 11 186 Funding Number: PA 11 186 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A National Coalition to Enhance STD/HIV Prevention through Promotion of a Holistic Approach to Health and Wellness Apply for CDC RFA PS11 1112 Funding Number: CDC RFA PS11 1112 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $135,000 |
| Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1) Apply for RFA AI 11 002 Funding Number: RFA AI 11 002 Agency: National Institutes of Health Category: Health Funding Amount: $19,000,000 |
| Initiatives to Educate State Officials and Policy Makers about Priority Public Health Issues Related to the Prevention and Control of Sexually Transmitted Diseases (STDs) and Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome ( Apply for CDC RFA PS11 1118 Funding Number: CDC RFA PS11 1118 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Eliminating Mother to Child HIV Transmission in the United States through Continuous Quality Improvement The FIMR HIV Prevention Methodology Apply for CDC RFA PS11 1116 Funding Number: CDC RFA PS11 1116 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| PPHF 2012 Immunization Capacity Building Assistance to Strengthen Public Health Immunization Infrastructure and Performance financed in part by 2012 Prevention and Public Health Funds Apply for CDC RFA IP11 1107PPHF11 Funding Number: CDC RFA IP11 1107PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Next Generation PrEP II (R01) Apply for RFA AI 11 023 Funding Number: RFA AI 11 023 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Cooperative Agreements for Screening, Brief Intervention and Referral to Treatment Apply for TI 11 005 Funding Number: TI 11 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $1,666,000 |
| Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54) Apply for PAR 11 187 Funding Number: PAR 11 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Optimizing Fidelity of Empirically Supported Behavioral Treatments for Mental Disorders (R21/R33) Apply for RFA MH 12 050 Funding Number: RFA MH 12 050 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Strengthening Angolan Systems for Health (SASH) Apply for RFA674 11 32 Funding Number: RFA674 11 32 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $33,000,000 |
| Support of NIAMS Program Project Grants (P01) Apply for PAR 11 188 Funding Number: PAR 11 188 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Dental Reimbursement Program Apply for HRSA 11 097 Funding Number: HRSA 11 097 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Public Health Prevention Fund Streamlined Surveillance for Ventilator Associated Pneumonia Reducing Burden and Demonstrating Preventability Apply for CDC RFA CK11 0010101PPHF11 Funding Number: CDC RFA CK11 0010101PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,508,825 |
| Public Prevention Health Fund Pacific Islands Supplemental Funding for Five Year US Affiliated Pacific Island Collaborative Performance Agreement for Tobacco Control, Diabetes Prevention and Control, and the Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9020302PPHF11 Funding Number: CDC RFA DP09 9020302PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $50,000 |
| Integrating Multi Dimensional Data to Explore Mechanisms Underlying Mental Disorders (RO1) Apply for RFA MH 12 020 Funding Number: RFA MH 12 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01) Apply for PAR 11 189 Funding Number: PAR 11 189 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Public Prevention Health Fund State Supplemental Funding for Healthy Communities, Tobacco Prevention and Control, Diabetes Prevention and Control, and Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 9010201PPHF11 Funding Number: CDC RFA DP09 9010201PPHF11 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| State Implementation Grants for Improving Services for Children and Youth with ASD Apply for HRSA 11 071 Funding Number: HRSA 11 071 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS11 1117", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.